Amicus Therapeutics (FOLD) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
FOLDAmicus Therapeutics(FOLD) ZACKS·2024-08-09 10:02

Amicus Therapeutics (FOLD) reported 126.67millioninrevenueforthequarterendedJune2024,representingayear−over−yearincreaseof34126.67 million in revenue for the quarter ended June 2024, representing a year-over-year increase of 34%. EPS of 0.06 for the same period compares to -0.15ayearago.Thereportedrevenuerepresentsasurpriseof+4.900.15 a year ago.The reported revenue represents a surprise of +4.90% over the Zacks Consensus Estimate of 120.76 million. With the consensus EPS estimate being $0.03, the EPS surprise was +100.00%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to ...